Company: INV
Filing Date: 2025-07-02
Form Type: 424B3
Source: 0001628280-25-034034
Chunk: 4

Company: Innventure, Inc.
Filing Date: 2025-07-02
Form: 424B3
Chunk 4
---
 Unit of Accelsius Holdings LLC over a base price of $12.175 (the “Spread”). In general, the SARs will be automatically exercised

upon the earliest to occur of: (a) the 24-month anniversary of the grant date, (b) the officer’s death, or (c) the officer’s “disability” (as defined in the applicable award agreement).

On June 25, 2025, each of Mr. Otworth and Dr. Scott entered into an amendment to his SAR award (each, a “SAR Amendment”) to (1) clarify that any payment by the Company to the applicable officer with respect to the SARs will be made in the form of shares of Common Stock and (2) to provide that the maximum number of shares of Common Stock that may be issued pursuant to each officer’s SAR award is 1,875,000 (the “Share Cap”). Under the SAR Amendment, the Company will not be required to pay either officer any amount in excess of the Share Cap (in the form of either equity or cash), even if the value of the number of shares of Common Stock issued in settlement of the SARs is less than the aggregate Spread as a result of the Share Cap.

The foregoing summary of the SAR Amendment is qualified in its entirety by reference to the text of the SAR Amendment, a form of which is included as Exhibit 10.4 and is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 25, 2025, the Company held its Annual Meeting of Stockholders (the “2025 Annual Meeting”). At the close of business on April 28, 2025, the record date for the 2025 Annual Meeting, there were (i) 53,487,294 shares of Common Stock issued and outstanding, each share entitled to one vote, (ii) 239,159 shares of Series B Preferred Stock, par value of $0.0001 per share (the “Series B Preferred Stock”), issued and outstanding, each share of Series B Preferred Stock entitled to 0.97 votes, and (iii) 575,000 shares of Series C Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”), issued and outstanding, each share of Series C Preferred Stock entitled to 1.3 votes, constituting all outstanding voting securities of the Company entitled to vote at the 2025 Annual Meeting.

At the